Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Perrone

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Cancer Research|June 5, 2007
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approachesGisella Volpe, Alessandro Cignetti, Cristina Panuzzo, et al.
Plos One|May 12, 2011
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patientsDaniele Santini, Gaia Schiavon, Bruno Vincenzi, et al.
Critical Reviews in Oncology/Hematology|December 1, 2023
Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: Practical indications from an Italian multidisciplinary groupUmberto Malapelle, Alessandro Delle Donne, Fabio Pagni, et al.
Molecular Cancer|June 6, 2014
Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patientsPaola Parrella, Raffaela Barbano, Barbara Pasculli, et al.
NPJ Digital Medicine|June 22, 2026
Handling missing modalities in multimodal survival prediction for non-small cell lung cancerFilippo Ruffini, Camillo Maria Caruso, Claudia Tacconi, et al.
Oncogene|May 21, 2021
Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edgeSimone Carotti, Maria Zingariello, Maria Francesconi, et al.
The Oncologist|December 6, 2008
High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practiceDaniele Santini, Fotios Loupakis, Bruno Vincenzi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2021
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgeryFederica Tavaglione, Antonio De Vincentis, Vincenzo Bruni, et al.
Cancers|May 28, 2022
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer PatientsFrancesco Pantano, Francesca Zalfa, Michele Iuliani, et al.
Cell Death & Disease|November 19, 2021
Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liverSimone Carotti, Daniele Lettieri-Barbato, Fiorella Piemonte, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Cancer Research|June 5, 2007
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approachesGisella Volpe, Alessandro Cignetti, Cristina Panuzzo, et al.
Plos One|May 12, 2011
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patientsDaniele Santini, Gaia Schiavon, Bruno Vincenzi, et al.
Critical Reviews in Oncology/Hematology|December 1, 2023
Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: Practical indications from an Italian multidisciplinary groupUmberto Malapelle, Alessandro Delle Donne, Fabio Pagni, et al.
Molecular Cancer|June 6, 2014
Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patientsPaola Parrella, Raffaela Barbano, Barbara Pasculli, et al.
NPJ Digital Medicine|June 22, 2026
Handling missing modalities in multimodal survival prediction for non-small cell lung cancerFilippo Ruffini, Camillo Maria Caruso, Claudia Tacconi, et al.
Oncogene|May 21, 2021
Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edgeSimone Carotti, Maria Zingariello, Maria Francesconi, et al.
The Oncologist|December 6, 2008
High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practiceDaniele Santini, Fotios Loupakis, Bruno Vincenzi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2021
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgeryFederica Tavaglione, Antonio De Vincentis, Vincenzo Bruni, et al.
Cancers|May 28, 2022
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer PatientsFrancesco Pantano, Francesca Zalfa, Michele Iuliani, et al.
Cell Death & Disease|November 19, 2021
Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liverSimone Carotti, Daniele Lettieri-Barbato, Fiorella Piemonte, et al.
Pageof 12